ValuEngine lowered shares of ICU Medical (NASDAQ:ICUI) from a buy rating to a hold rating in a report published on Tuesday, September 18th.

Other analysts have also recently issued research reports about the company. TheStreet upgraded ICU Medical from a c+ rating to a b+ rating in a research report on Monday, August 20th. Zacks Investment Research upgraded ICU Medical from a hold rating to a strong-buy rating and set a $337.00 price objective for the company in a research report on Wednesday, August 15th. One equities research analyst has rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $337.00.

Shares of NASDAQ ICUI traded up $4.95 during mid-day trading on Tuesday, hitting $265.80. 167,031 shares of the company were exchanged, compared to its average volume of 157,986. ICU Medical has a 1-year low of $180.45 and a 1-year high of $321.70. The company has a market cap of $5.79 billion, a PE ratio of 48.15 and a beta of 0.41.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $1.82 by $0.84. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The company had revenue of $360.46 million during the quarter, compared to the consensus estimate of $337.60 million. During the same quarter last year, the company earned $0.76 earnings per share. ICU Medical’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, research analysts expect that ICU Medical will post 7.6 EPS for the current year.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 787 shares of ICU Medical stock in a transaction dated Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total value of $238,555.44. Following the completion of the sale, the vice president now owns 1,367 shares in the company, valued at approximately $414,365.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Pfizer Inc sold 700,000 shares of ICU Medical stock in a transaction dated Monday, August 13th. The shares were sold at an average price of $284.35, for a total value of $199,045,000.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 711,920 shares of company stock valued at $202,651,956. 12.50% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of ICU Medical during the 2nd quarter worth about $235,000. Smith Asset Management Group LP grew its holdings in shares of ICU Medical by 1,207.6% during the 2nd quarter. Smith Asset Management Group LP now owns 38,745 shares of the medical instruments supplier’s stock worth $11,377,000 after purchasing an additional 35,782 shares during the period. Legal & General Group Plc grew its holdings in shares of ICU Medical by 18.1% during the 2nd quarter. Legal & General Group Plc now owns 17,686 shares of the medical instruments supplier’s stock worth $5,193,000 after purchasing an additional 2,706 shares during the period. Baird Financial Group Inc. lifted its position in ICU Medical by 0.5% during the 2nd quarter. Baird Financial Group Inc. now owns 49,781 shares of the medical instruments supplier’s stock worth $14,618,000 after acquiring an additional 245 shares in the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new position in ICU Medical during the 2nd quarter worth approximately $5,849,000. Institutional investors own 74.29% of the company’s stock.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

See Also: Marijuana Stocks Future Looks Bright

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.